EICHORCondition: Heart Failure · Sponsor: Medisch Spectrum Twente
The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are: 1. To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms. 2. To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS). Participants will wear a smartwatch for six months and perform an I-lead ecg with the smartwatch weekly.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Adult HF patients * NYHA class II, or NYHA III * Recent rehospitalization for HF * Usual care with active participation in the telemonitoring program "Zorg Bij Jou" (ZBJ) * Possession of an iPhone 11 or newer and compatible with the study apps Exclusion Criteria: * Lack of digital literacy or inability to use the device * Not capable to sign consent * Referral to hospice
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Medisch Spectrum Twente | Enschede, Netherlands | — |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07689760